Scientists at Nagoya City University target pneumonia
2009 JUN 29 - (NewsRx.com) -- According to recent research from Nagoya, Japan, "A case of acute necrotizing pancreatitis due to Mycoplasma pneumoniae infection was treated in an 8-year-old girl. She experienced acute pancreatitis during treatment for M. pneumoniae." "Contrast-enhanced computed tomographic scan revealed necrotizing pancreatitis. The computed tomographic severity index was 8 points (grade E). A protease inhibitor, ulinastatin, was provided via intravenous infusion but was ineffective. Continuous regional arterial infusion therapy was provided with gabexate mesilate (FOY-007, a protease inhibitor) and meropenem trihydrate, and the pancreatitis improved," wrote M. Nakagawa and colleagues, Nagoya City University. The researchers concluded: "This case suggests that infusion therapy is safe and useful in treating necrotizing pancreatitis in children." Nakagawa and colleagues published their study in Cardiovascular and Interventional Radiology (Continuous Regional Arterial Infusion Therapy for Acute Necrotizing Pancreatitis Due to Mycoplasma pneumoniae Infection in a Child. Cardiovascular and Interventional Radiology, 2009;32(3):581-584). For additional information, contact M. Nakagawa, Nagoya City University, Graduate School of Medicine Science, Dept. of Radiol, Mizuho Ku, 1 Kawasumi, Mizuho Cho, Nagoya, Aichi 4678601, Japan. Publisher contact information for the journal Cardiovascular and Interventional Radiology is: Springer, 233 Spring St., New York, NY 10013, USA. Keywords: Japan, Nagoya, Acute Necrotizing Pancreatitis, Acute Pancreatitis, Cardiology, Cardiovascular, Enzymology, Infectious Disease, Mycoplasma, Pneumonia, Protease Inhibitors, Pulmonology, Radiology, Therapy, Treatment, Nagoya City University. This article was prepared by Biotech Business Week editors from staff and other reports. Copyright 2009, Biotech Business Week via NewsRx.com.
|
